[HTML][HTML] Progesterone receptor membrane component 1 leads to erlotinib resistance, initiating crosstalk of Wnt/β-catenin and NF-κB pathways, in lung …
Y Lin, K Higashisaka, T Shintani, A Maki… - Scientific reports, 2020 - nature.com
In non-small-cell lung cancer, mutation of epidermal growth factor receptor (EGFR)
stimulates cell proliferation and survival. EGFR tyrosine kinase inhibitors (EGFR-TKIs) such …
stimulates cell proliferation and survival. EGFR tyrosine kinase inhibitors (EGFR-TKIs) such …
Progesterone receptor membrane component 1 leads to erlotinib resistance, initiating crosstalk of Wnt/β-catenin and NF-κB pathways, in lung adenocarcinoma cells.
Y Lin, K Higashisaka, T Shintani, A Maki… - Scientific …, 2020 - search.ebscohost.com
In non-small-cell lung cancer, mutation of epidermal growth factor receptor (EGFR)
stimulates cell proliferation and survival. EGFR tyrosine kinase inhibitors (EGFR-TKIs) such …
stimulates cell proliferation and survival. EGFR tyrosine kinase inhibitors (EGFR-TKIs) such …
Progesterone receptor membrane component 1 leads to erlotinib resistance, initiating crosstalk of Wnt/β-catenin and NF-κB pathways, in lung adenocarcinoma cells.
Y Lin, K Higashisaka, T Shintani, A Maki… - Scientific …, 2020 - europepmc.org
In non-small-cell lung cancer, mutation of epidermal growth factor receptor (EGFR)
stimulates cell proliferation and survival. EGFR tyrosine kinase inhibitors (EGFR-TKIs) such …
stimulates cell proliferation and survival. EGFR tyrosine kinase inhibitors (EGFR-TKIs) such …
[HTML][HTML] Progesterone receptor membrane component 1 leads to erlotinib resistance, initiating crosstalk of Wnt/β-catenin and NF-κB pathways, in lung …
Y Lin, K Higashisaka, T Shintani, A Maki… - Scientific …, 2020 - ncbi.nlm.nih.gov
In non-small-cell lung cancer, mutation of epidermal growth factor receptor (EGFR)
stimulates cell proliferation and survival. EGFR tyrosine kinase inhibitors (EGFR-TKIs) such …
stimulates cell proliferation and survival. EGFR tyrosine kinase inhibitors (EGFR-TKIs) such …
Progesterone receptor membrane component 1 leads to erlotinib resistance, initiating crosstalk of Wnt/β-catenin and NF-κB pathways, in lung adenocarcinoma cells
Y Lin, K Higashisaka, T Shintani, A Maki… - Scientific Reports, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> In non-small-cell lung cancer, mutation of
epidermal growth factor receptor (EGFR) stimulates cell proliferation and survival. EGFR …
epidermal growth factor receptor (EGFR) stimulates cell proliferation and survival. EGFR …
Progesterone receptor membrane component 1 leads to erlotinib resistance, initiating crosstalk of Wnt/β-catenin and NF-κB pathways, in lung adenocarcinoma cells
Y Lin, K Higashisaka, T Shintani, A Maki… - Scientific …, 2020 - pubmed.ncbi.nlm.nih.gov
In non-small-cell lung cancer, mutation of epidermal growth factor receptor (EGFR)
stimulates cell proliferation and survival. EGFR tyrosine kinase inhibitors (EGFR-TKIs) such …
stimulates cell proliferation and survival. EGFR tyrosine kinase inhibitors (EGFR-TKIs) such …
Progesterone receptor membrane component 1 leads to erlotinib resistance, initiating crosstalk of Wnt/β-catenin and NF-κB pathways, in lung adenocarcinoma cells
Y Lin, K Higashisaka, T Shintani, A Maki… - Scientific …, 2020 - ui.adsabs.harvard.edu
In non-small-cell lung cancer, mutation of epidermal growth factor receptor (EGFR)
stimulates cell proliferation and survival. EGFR tyrosine kinase inhibitors (EGFR-TKIs) such …
stimulates cell proliferation and survival. EGFR tyrosine kinase inhibitors (EGFR-TKIs) such …